Who Paid My Doc
Maria Valdes
Behavioral Neurology & Neuropsychiatry Clermont, FL Medical Doctor
NPI 1144351636 CMS profile 279077
2140 N Don Wickham Dr, Clermont, FL 34711
General payments
$1,714
Research payments
$0
Ownership & investment interest
$0
Through program year 2024, Maria Valdes of Clermont, FL is reported in the CMS Open Payments database as having received $1,714 across 117 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 69th percentile of Behavioral Neurology & Neuropsychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
5 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $19 | 1 | |
| 2022 | General | $282 | 6 | |
| 2021 | General | $913 | 55 | |
| 2020 | General | $69 | 5 | |
| 2019 | General | $431 | 50 |
Beside peers
- Maria Valdes
- Behavioral Neurology & Neuropsychiatry median
- Middle half of Behavioral Neurology & Neuropsychiatry
- National median
In program year 2025, general payments to Maria Valdes were reported at $0. Among 74 Behavioral Neurology & Neuropsychiatry profiles paid that year, the median was $152 and the middle half received between $53 and $1,035.
Show as a table
| Year | Maria Valdes | Behavioral Neurology & Neuropsychiatry median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $431 | $211 | $86–$990 | $163 |
| 2020 | $69 | $270 | $54–$1,600 | $114 |
| 2021 | $913 | $267 | $60–$1,036 | $132 |
| 2022 | $282 | $255 | $69–$1,314 | $149 |
| 2023 | $0 | $170 | $50–$1,103 | $160 |
| 2024 | $19 | $173 | $39–$1,488 | $164 |
| 2025 | $0 | $152 | $53–$1,035 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 29 drugsPart D claims
1,102
Drug cost
$33,754
Branded share of claims
15.7%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Rexulti Brexpiprazole | Brand | 12 | $17,377 | |
| Aripiprazole | Generic | 57 | $2,257 | |
| Trazodone Hcl | Generic | 100 | $2,240 | |
| Clonazepam | Generic | 182 | $1,988 | |
| Hydroxyzine Hcl | Generic | 59 | $1,243 | |
| Duloxetine Hcl | Generic | 62 | $1,037 | |
| Lurasidone Hcl | Generic | 13 | $892 | |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | Brand | 12 | $652 | |
| Bupropion Xl Bupropion Hcl | Brand | 64 | $551 | |
| Quetiapine Fumarate | Generic | 37 | $524 |
The 10 drugs with the highest cost, of 29 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 20,488 Part D prescribers listed as Psychiatry; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 3 billing codesPaid by Medicare
$4,348
Medicare patients
13
Services billed
68
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| Atrial fibrillation | 0% | |
| COPD | 0% | |
| Osteoporosis | 0% | |
| Alzheimer's or dementia | 0% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
117 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Behavioral Neurology & Neuropsychiatry in Florida
James Galvin
Behavioral Neurology & Neuropsychiatry · Boca Raton, FL
Abid Darr
Behavioral Neurology & Neuropsychiatry · Leesburg, FL
David Burtis
Behavioral Neurology & Neuropsychiatry · Gainesville, FL
Leilani Davis
Behavioral Neurology & Neuropsychiatry · Miami, FL
Julie Kessel
Behavioral Neurology & Neuropsychiatry · St Petersburg, FL
Maria Hubbard
Behavioral Neurology & Neuropsychiatry · Key Biscayne, FL
Related records
Behavioral Neurology & Neuropsychiatry in Florida
Practitioners in the same specialty and state, ranked by reported value.
All Behavioral Neurology & Neuropsychiatry
Everyone recorded under this specialty, nationwide.
Doctors in Florida
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.